Scientific poster: Development of a robust and scalable hiPSC platform for the identification of efficacious and less toxic ASOs
Research highlights: Targeted Protein Degradation in Tauopathies
Case Study: Development of a human iPSC-derived ALS model
-1.png)
The status of drug discovery and development for Parkinson's disease
Uncovering ALS pathology and potential drug targets with in vitro iPSC models
The status of drug discovery and development for Alzheimer's disease
Subscribe to our newsletter
Stay up to date on iPSC innovations, events and news.
